The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and…
Please select a star rating
Please enter valid youtube video url
Please write a review
Connect with
